 | Up a level |
Rathore , Yogesh and Shukla , Jaya and Laroiya, Ishita and Deep , Amar and Lakhanpal , Tamanna and Kumar , Rajender and Singh , Harmandeep and Bal, Amanjit and Singh , Gurpreet and Thakur , Krishan Gopal and Mittal , B R (2022) Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients. Nuclear Medicine Communications , 43 (4). pp. 458-467.
Rathore, Yogendra S and Shukla, Jinal and Mittal, BR and Singh, G and Gopal, K. and Kumar, R and Bal, Amanjit and Laroiya, I and Lakhanpal, T (2021) Radiolabelled trastuzumab Fab as a theranostic molecule for HER2 positive breast cancers. ANNALS OF ONCOLOGY, 32 (2). ISSN 0923-7534
Jacob, Neenu and Jaiswal, Shivani and Maheshwari, Deep and Nallabelli, Nayudu and Khatri, Neeraj and Bhatia, Alka and Bal, Amanjit and Malik, Vivek and Verma, Savita and Kumar, Rakesh and Sachdeva, Naresh (2020) Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Scientific reports, 10 (1). ISSN 2045-2322
